<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04197570</url>
  </required_header>
  <id_info>
    <org_study_id>IRB19-024</org_study_id>
    <nct_id>NCT04197570</nct_id>
  </id_info>
  <brief_title>Opioid-free Anesthesia for Open Cardiac Surgery: A Prospective Randomized Controlled Trial</brief_title>
  <official_title>Opioid-free Anesthesia for Open Cardiac Surgery: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benaroya Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virginia Mason Hospital/Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Benaroya Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare an opioid free anesthetic, using dexmedetomidine, to a traditional
      opioid based anesthetic, using fentanyl, for patients undergoing cardiac surgery with regards
      to hemodynamic stability in the first 10 minutes after induction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, blinded, prospective, randomized controlled trial. A total of 158
      subjects (79 subjects in each arm) are planned. The control group will receive a traditional
      cardiac anesthetic using opioids, for which induction will include fentanyl and propofol. The
      experimental arm will receive an opioid free anesthetic with an induction bolus of
      dexmedetomidine and propofol. The investigators hypothesize that using the opioid free
      technique will be more hemodynamically stable within the first 10 minutes of induction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 4, 2020</start_date>
  <completion_date type="Actual">March 14, 2020</completion_date>
  <primary_completion_date type="Actual">March 14, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The investigators plan to enroll 158 subjects at Virginia Mason Medical Center that are undergoing open cardiac surgery. Subjects who volunteer to be involved in the study will be randomized to either the opioid free or traditional anesthetic arm. Subjects will be blinded to the assigned arm.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean arterial blood pressure-time integral</measure>
    <time_frame>10 minutes</time_frame>
    <description>The primary endpoint is the area under the baseline mean arterial pressure (MAP) over the first 10 minutes after induction, called the MAP-time integral.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure variability pre-cardiopulmonary bypass</measure>
    <time_frame>2 hours</time_frame>
    <description>highest and lowest blood pressure from induction to start of bypass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability pre-cardiopulmonary bypass</measure>
    <time_frame>2 hours</time_frame>
    <description>highest and lowest heart rate from induction to start of bypass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasopressor usage intra- and post-operatively</measure>
    <time_frame>18 hours</time_frame>
    <description>Number of vasopressors and doses from induction to start of cardiopulmonary bypass, leaving operating room and 12 hours postop</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arrhythmias or EKG changes</measure>
    <time_frame>14 days</time_frame>
    <description>Intraoperative EKG changes or evidence of echocardiographic ischemia prior to heparin. Antiarrhythmic medications given intraoperative or in first 24 hours postop. New permanent pacemaker placed during hospital admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium medications</measure>
    <time_frame>24 hours</time_frame>
    <description>Delirium medications administered 24 hours after ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>24 hours</time_frame>
    <description>CAM-ICU scores at 12 hours and 24 hours after ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain scores</measure>
    <time_frame>24 hours</time_frame>
    <description>Numerical Rating Scale Pain Scores (Range: 0-10, where 0 is no pain and 10 is the worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Total opioid utilization 24hours postoperatively (morphine equivalent dose)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea/vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of antiemetic doses administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>1-36 hours</time_frame>
    <description>Time from arrival in ICU to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>1-5 days</time_frame>
    <description>Time from arrival in ICU to time of transfer order out of ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>3-14 days</time_frame>
    <description>Time begins day of surgery to day of discharge. Time in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reintubation or readmission to ICU</measure>
    <time_frame>0-14 days</time_frame>
    <description>After being extubated or being transferred out of ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major adverse cardiovascular event or mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Major adverse cardiovascular event (eg., myocardial ischemia, stroke) or death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>30 day, 3 month and 6 month pain questionnaire as well as post-sternotomy opioid use (as determined by reviewing Washington PMP data). Numerical Rating Scale Pain Scores (Range: 0-10, where 0 is no pain and 10 is the worst pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Opioid Use</condition>
  <condition>Heart; Surgery, Heart, Functional Disturbance as Result</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Opioid-based anesthetic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Premedication
-midazolam 2mg IV x 1 as need for anxiety, at the discretion of the anesthesiologist
Induction
Fentanyl 2-4 mcg/kg IV bolus
Propofol 1-3 mg/kg IV
Paralytic and vasoactive medications at the discretion of the anesthesiologist
Maintenance
Fentanyl 1-2 mcg/kg IV bolus immediately prior to sternotomy &amp; aortic cannulation
Fentanyl 1-2mcg/kg IV bolus immediately following removal of bypass cannula
Dexmedetomidine 0.4 mcg/kg/hr IV infusion
Isoflurane titrated at the discretion of the anesthesiologist
Vasoactive medications at the discretion of the anesthesiologist for hemodynamic management
During chest closure:
start Propofol 25-75mcg/kg/min IV infusion
continue dexmedetomidine 0.4mcg/kg/hr IV infusion
titrate off isoflurane
Acetaminophen 1000mg IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid-free anesthetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Premedication
-midazolam 2mg IVx1 as needed for anxiety, at the discretion of the anesthesiologist
Induction
Dexmedetomidine 1mcg/kg IV
Propofol 1-3mg/kg IV
Paralytic and vasoactive medications at the discretion of the anesthesiologist
Maintenance
Dexmedetomidine 0.8-1.0 mcg/kg/hr IV infusion
Isoflurane titrated at the discretion of the anesthesiologist
May add propofol infusion if clinically indicated
Vasoactive medications at the discretion of the anesthesiologist for hemodynamic management
During chest closure:
start Propofol 25-75mcg/kg/min IV infusion
continue dexmedetomidine 0.4 - 1.0 mcg/kg/hr IV infusion
titrate off isoflurane
Acetaminophen 1000mg IV</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioid Anesthetics</intervention_name>
    <description>see arm/group description</description>
    <arm_group_label>Opioid-based anesthetic</arm_group_label>
    <other_name>Opioid-based anesthetic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Non Opioid Analgesics</intervention_name>
    <description>see arm/group description</description>
    <arm_group_label>Opioid-free anesthetic</arm_group_label>
    <other_name>Opioid-free anesthetic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female â‰¥ 18 years of age at the time of consent.

          -  Undergoing non-emergent open cardiac procedures requiring cardiopulmonary bypass
             support, including: CABG, aortic aneurysm repair, valve repair/replacement, or CABG in
             combination with valve repair/replacement.

          -  Ability and willingness to provide written informed consent.

        Exclusion Criteria:

          -  Chronic opioid use defined as preoperative MED &gt;100 daily.

          -  Hypersensitivity or contraindication to any of the study medications.

          -  Pre-existing Alzheimer's/vascular dementia.

          -  Pre-existing psychiatric disorder precluding ability to provide informed consent or
             use a visual analogue scale for pain.

          -  Childs-Pugh Class C liver failure or acute liver failure.

          -  Emergent open heart surgery, including type A aortic dissections, trauma, or
             conversion (bail out) from another procedure such as cardiac catheterization,
             ablation, transcatheter aortic valve replacement or any other general surgical
             procedure.

          -  Pregnancy or lactating.

          -  Inability to comply with the requirements of the study, per investigator judgment.

          -  Patients determined to need an awake intubation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Bain</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Mason Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>December 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Opioid Free Anesthesia</keyword>
  <keyword>Cardiac Surgery</keyword>
  <keyword>Non-opioid Anesthesia</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Hemodynamic</keyword>
  <keyword>Opioid</keyword>
  <keyword>Fentanyl</keyword>
  <keyword>Cardiac Anesthesia</keyword>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>post sternotomy pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Analgesics, Non-Narcotic</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

